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Abstract: Recently, the FokI polymorphism (rs2228570) in the vitamin D receptor gene 
(VDR) and conventional risk factors were associated with spine disorders in the Italian 
population, but without gender analysis. Two-hundred and sixty-seven patients (149 males, 
118 females) with lumbar spine disorders were assessed by magnetic resonance imaging 
(MRI) and 254 (127 males, 127 females) asymptomatic controls were enrolled. The exposure 
to putative risk factors was evaluated and FokI polymorphism was detected by PCR-restriction 
fragment length polymorphism (PCR-RFLP). An association between lumbar spine 
pathologies and higher than average age; overweight; family history; lower leisure  
physical activity; smoking habit; higher number of hours/day exposure to vibration and 
more sedentary or intense physical job demand was observed in male patients. In contrast,  
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in females, only higher age, overweight, family history and lower leisure physical  
activity were risk factors. FF genotype was a 2-fold risk factor to develop discopathies  
and/or osteochondrosis concomitant with disc herniation for both gender patients, while 
heterozygous Ff was protective for females only. In males only ff genotype was protective  
for discopathies and/or osteochondrosis and F allele was a 2-fold risk factor for hernia; 
discopathies; discopathies and/or osteochondrosis. Sex-related differences in voluntary 
behaviors, exposure to environmental risks and genetic background could be crucial for  
a gender-differentiated management of patients with spine disorders. 
Keywords: vitamin D receptor; polymorphism; lumbar spine pathologies; risk factors; 
gender-related differences; Italian population 
 
1. Introduction 
Since 1998 the vitamin D receptor gene (VDR) has been studied as a genetic factor putatively 
predisposing to spine pathologies [1,2]. The C > T single nucleotide polymorphism FokI (rs10735810, 
merged into rs2228570) in the VDR sequence represents an independent polymorphic site, affecting 
the structure and the function of the encoded protein [3]. The allelic variants of this exonic 
polymorphism code for a structurally different receptor protein, from a 424 amino acids long wild-type 
encoded by the F allele (C) to a 427 amino acids long protein produced by the f allele (T), associated to 
a different efficiency of VDR binding with the transcription factor II B (TFIIB) [4,5]. This results in  
a different ability to induce transcription of vitamin D-dependent genes with the shorter wild-type 
protein interacting more efficiently with TFIIB and showing a higher transcriptional rate [3,6]. Based 
on these studies, investigations concerning the possible association of the VDR-FokI polymorphism with 
disc degeneration may be particularly interesting. 
Established evidence indicates that the vitamin D endocrine system is involved in the modulation of 
skeletal metabolism, immunological response, proliferation and differentiation of a wide variety of cell 
types [7–10]. Vitamin D action mediated by its receptor appears to be selective and to vary depending on 
cell type [10,11]. Recent findings detected the presence of VDR in the human intervertebral disc  
nucleus pulposus and annulus fibrosus cells and showed that vitamin D active metabolites regulate 
proliferation, matrix genes expression and specific cytokine and protein production of disc cells [12,13]. 
These in vitro studies indicated that the biologic interaction of disc cells with the vitamin D metabolites 
may influence disc health; consequently altered vitamin D signaling could have a role in the 
pathophysiology of disc degeneration. 
The association of the VDR-FokI polymorphism with lumbar spine pathologies implicating lumbar  
disc degeneration [2,14–17] and the influence of non-genetic factors like exposure to occupational 
vibration [18,19] have been investigated in different populations with inconsistent results. 
Discrepancies in the reported findings [20] could derive from the lack of a consistent definition of the 
lumbar spine pathological phenotypes analyzed and by the differences associated with the specific ethnic 
group examined. 
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Very recently, in an Italian case-control study, we reported that the VDR-FokI polymorphism  
and conventional, behavioral and environmental factors were associated with lumbar spine  
pathologies [21]. In the previous work we evaluated the overall population of cases in comparison with 
asymptomatic controls, without taking into account possible gender effects. However, sex-related 
differences were noted recently in several diseases [22] and in particular in musculoskeletal  
disorders [23]. Interestingly, some gender differences were noted when reporting spine pain, with 
females being more likely to report neck and back pain, and males being more likely to have a higher 
number of days absent from work and diagnosed hernia [24]. Thus, sex-unstratified analyses could 
lead to missing specific gender effects in the observed association of spine disorders and risk factors. 
To our knowledge, no study explored the gender-related interplay between the VDR-FokI 
polymorphism and conventional risk factors predisposing to lumbar spine pathologies in the Italian 
population. The aims of this study were to evaluate in VDR-FokI frequency distributions and 
conventional risk factors separately in Italian males and females with specific lumbar spine pathologies 
compared to asymptomatic controls. 
2. Results 
2.1. Influences of Conventional, Behavioral and Environmental Risk Factors According to Gender 
The putative non-genetic categorical risk factors associated to all lumbar spine diseases in the 
overall population and in males or females were shown in Table 1. Cases and controls did not differ by 
gender (p = 0.19). Males and females did not differ by age (p = 0.70). 
In the overall cohort of cases, age over 45 years or over 50 years, overweight or obesity, family 
history, past and present smoking habit, present smoking ≥10 cigarettes per day, and more than sedentary 
or intense job physical demand were all significantly associated with the development of lumbar spine 
pathologies, with significant ORs (odds ratio) ranging approximately from 2 to 3. Of note, present 
smoking ≥20 cigarettes per day had an elevated OR = 6.05; 95% CI (95% confidence interval) =  
1.76–20.8; p = 0.001. A strong dose-response effect was observed concerning the increasing numbers of 
hours/day of exposure to vehicular vibration; the increased risk to develop spine pathologies ranged 
from a 1.6-fold at >1 h/day, to 2.9-fold at >2 h/day, to 3.7-fold at >3 h/day and to 8.5-fold increased 
risk at >4 h/day of vibration exposure. In our Italian cohort, controls subjects practiced leisure physical 
activity at least once per week 2-fold more frequently than the pathological subjects (OR = 1.98; 95% 
CI = 1.50–2.62; p < 0.001). 
Almost all the associations found for the entire cohort were confirmed for male patients compared to 
male controls, the only exceptions were an age ≥50 years and present smoking (both these categories 
corresponded to tendencies in males). Notably, family history was a six-fold risk factor for males. 
Unexpectedly, for female patients compared to female controls the only conventional risk factors 
significantly associated with an approximately 2- to 3-fold increased risk for lumbar spine pathologies 
were age ≥45 to ≥50 years, overweight, and family history. Additionally, in females, a lower frequency 
of spine pathologies was associated with leisure physical activity once or more or twice or more per 
week. Thus, a remarkable gender difference was noted in regard to association of lumbar spine disease 
with physical job demand and exposure to vibrations. Particularly, intense physical job demand was 
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associated to a six-fold increased risk for men, while it was indifferent for women. However, it is to 
note that, in our cohort, males and females differed in frequency of intense physical job demand  
(p = 0.003). Women had in general less risky behaviors, for example, percentages of smokers were not 
different between genders, but males more than females smoked ≥10 cigarettes/day (p = 0.023) or  
≥20 cigarettes/day (p = 0.030), indeed, only very few females (n = 5) smoked ≥20 cigarettes/day vs.  
16 males. Moreover, women were exposed to less severe environmental risk factors, exposure to 
vibration over 1 h/day was more frequent in males than in females (p < 0.001), notably only 1 woman  
(a case) in the entire sample was exposed to more than 4 h of vibrations/day vs. 35 males (31 cases and 
4 controls), p < 0.001. 
2.2. VDR-FokI Genotypes and Alleles According to Gender 
Data concerning the FokI genotypes in the entire cohort of 521 subjects (267 cases and 254 controls) 
and gender-related were reported in Table 2. Male and female cases and controls did not differ in 
genotype frequencies. The VDR-FokI genotypes were in Hardy-Weinberg equilibrium (HWE) in male 
controls (χ2 = 0.49, p = 0.48), female controls (χ2 = 0.15, p = 0.69), male cases (χ2 = 0.38, p = 0.54), 
and female cases (χ2 = 0.11, p = 0.74). 
Concerning the genotype frequencies of all pathological cases compared with controls, we did  
not observe significant differences, with the exception of a just significant lower frequency of the 
homozygous ff genotype in male cases (8.1%) than in male controls (15.7%); crude OR = 0.47;  
95% CI = 0.22–1.00; p = 0.047). However, the observed significant difference for ff in males was lost 
after adjustment for conventional risk factors. Moreover, in the male cohort there was a tendency for 
an association of the F allele with lumbar spine pathologies (69.8% of cases vs. 62.2% of controls; crude 
OR = 1.40; 95% CI = 0.99–2.00; p = 0.060); thus, for the f allele there was a protective tendency. 
Confirmatory with our previous investigation [21], by cumulative analysis including both genders, 
significant FF associations were found for some specific patients; Subgroup 2 (i.e., discopathies and/or 
osteochondrosis with disc herniation), crude OR = 1.95; 95% CI = 1.19–3.20, p = 0.007; adjusted  
OR = 2.09; 95% CI = 1.19–3.66, p = 0.011, and Subgroup C (i.e., all discopathies), crude OR = 2.08; 
95% CI = 1.19–3.62, p = 0.009; adjusted OR = 1.88; 95% CI = 1.03–3.43, p = 0.039. The ff genotype 
was protective in crude analysis only for Subgroup B (i.e., all discopathies and/or osteochondrosis), 
crude OR = 0.46; 95% CI = 0.22–0.99, p = 0.043, adjusted OR = 0.42; 95% CI = 0.18–1.00, p = 0.051; 
and for Subgroup D (i.e., all osteochondrosis) crude OR = 0.25; 95% CI = 0.06–1.08, p = 0.047, adjusted 
OR = 0.23; 95% CI = 0.05–1.17, p = 0.078. The complete data analysis of genotype association in 
different pathologic Subgroups not stratified for sex was reported in Supplementary Table S1. 
Gender-related analysis of genotypes in pathological Subgroups was shown in Tables 3 (males) and 4 
(females). Regarding the male population (Table 3), in Subgroup 2 the FF genotype had a frequency of 
52.7% vs. 40.2% of male controls (crude OR not significant; adjusted OR = 2.32; 95% CI = 1.02–5.30,  
p = 0.045). Moreover, in Subgroup A and C the FF genotype had a tendency for risk. In males, the ff 
genotype was protective in crude analysis for Subgroup A (crude OR = 0.39; 95% CI = 0.16–0.96,  
p = 0.036) and Subgroup 1 + 2 + 3 (all patients excluding stenosis and/or spondilolysthesis) (crude  
OR = 0.42; 95% CI = 0.18–0.96, p = 0.035). Finally, the ff genotype was protective for Subgroup B in 
adjusted analysis (adjusted OR = 0.23; 95% CI = 0.06–0.88, p = 0.032). 
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Table 1. Categorical risk factors for all subjects (n = 521), and for males (n = 276) or females (n = 245) controls and cases. 
Categorical 
Variable 
All Controls  
n = 254 
All Cases  
n = 267 
OR (95% CI)  
p Value 
Male Controls 
n = 127 (50.0%) 
Male Cases  
n = 149 (55.8%) 
OR (95% CI)  
p Value 
Female Controls 
n = 127 (50.0%) 
Female Cases 
n = 118 (44.2%) 
OR (95% CI)  
p Value 
Age ≥ 45 years 79 (31.1) 136 (50.9) 2.30 (1.61–3.29) p < 0.001 41 (32.3) 72 (48.3) 1.96 (1.20–3.21) p = 0.007 38 (29.9) 64 (54.2) 2.78 (1.64–4.69) p < 0.001 
Age ≥ 50 years 45 (17.7) 83 (31.1) 2.10 (1.39–3.17) p < 0.001 23 (18.1) 40 (26.8) 1.66 (0.93–2.96) p = 0.085 22 (17.3) 43 (36.4) 2.74 (1.51–4.95) p = 0.001 
BMI ≥ 25.0 kg/m2 87 (34.3) 132 (49.4) 1.88 (1.32–2.67) p < 0.001 61 (48.0) 92 (61.7) 1.75 (1.08–2.82) p = 0.022 26 (20.5) 40 (33.9) 1.99 (1.12–3.54) p = 0.018 
BMI ≥ 30.0 kg/m2 17 (6.7) 37 (13.9) 2.24 (1.23–4.10) p = 0.007 11 (8.7) 27 (18.1) 2.33 (1.11–4.92) p = 0.023 6 (4.7) 10 (8.5) 1.87 (0.66–5.31) 
Family history 37 (14.6) 97 (36.3) 3.35 (2.18–5.14) p < 0.001 13 (10.2) 61 (40.9) 6.08 (3.14–11.8) p < 0.001 24 (18.9) 36 (30.5) 1.88 (1.04–3.41) p = 0.035 
Past and  
present smoking 
104 (40.9) 144 (53.9) 1.69 (1.19–2.39) p = 0.003 61 (48.0) 93 (62.4) 1.80 (1.11–2.91) p = 0.016 43 (33.9) 51 (43.2) 1.49 (0.89–2.50) 
Present smoking 57 (22.4) 86 (32.2) 1.64 (1.11–2.43) p = 0.013 31 (24.4) 52 (34.9) 1.66 (0.98–2.81) p = 0.058 26 (20.5) 34 (28.8) 1.57 (0.87–2.83) 
Smoking  
≥ 10 cigarettes/day 23 (9.1) 54 (20.2) 2.55 (1.51–4.29) p < 0.001 12 (9.4) 38 (25.5) 3.28 (1.63–6.60) p = 0.001 11 (8.7) 16 (13.6) 1.65 (0.73–3.73) 
Smoking  
≥ 20 cigarettes/day 3 (1.2) 18 (6.7) 6.05 (1.76–20.8) p = 0.001 1 (0.8) 15 (10.1) 14.1 (1.84–108) p = 0.001 2 (1.6) 3 (2.5) 1.63 (0.27–9.93) 
Physical job demand 
more than sedentary 
155 (61.0) 192 a (73.3) 1.75 (1.21–2.54) p = 0.003 71 (55.9) 110 (74.8) b 2.35 (1.41–3.91) p = 0.001 84 (66.1) 82 (71.3) d 1.27 (0.74–2.20) 
Medium or intense 91 (35.8) 117 a (44.7) 1.45 (1.02–2.06) p = 0.041 40 (31.5) 80 (54.4) b 2.60 (1.58–4.26) p < 0.001 51 (40.2) 37 (32.2) d 0.71 (0.42–1.20) 
Intense 21 (8.3) 53 a (20.2) 2.81 (1.64–4.82) p < 0.001 8 (6.3) 43 (29.3) b 6.15 (2.77–13.7) p < 0.001 13 (10.2) 10 (8.7) d 0.84 (0.35–1.99) 
Exposure to vibration 
> 0 h/day 
219 (86.2) 218 (81.6) 0.71 (0.44–1.14) 111 (87.4) 127 (85.2) 0.83 (0.42–1.66) 108 (85.0) 91 (77.1) 0.59 (0.31–1.14) 
Exposure to vibration 
> 1 h/day 
89 (35.0) 124 (46.4) 1.61 (1.13–2.29) p = 0.008 47 (37.0) 86 (57.7) 2.32 (1.43–3.77) p = 0.001 42 (33.1) 38 (32.2) 0.96 (0.56–1.64) 
Exposure to vibration 
> 2 h/day 
26 (10.2) 66 (20.7) 2.88 (1.76–4.71) p < 0.001 14 (11.0) 52 (34.9) 4.33 (2.26–8.28) p < 0.001 12 (9.4) 14 (11.9) 1.29 (0.57–2.92) 
Exposure to vibration 
> 3 h/day 
13 (5.1) 44 (16.5) 3.66 (1.92–6.97) p < 0.001 7 (5.5) 39 (26.2) 6.08 (2.61–14.2) p < 0.001 6 (4.7) 5 (4.2) 0.89 (0.27–3.01) 
Exposure to vibration 
> 4 h/day 
4 (1.6) 32 (12.0) 8.51 (2.97–24.4) p < 0.001 4 (3.1) 31 (20.8) 8.08 (2.77–23.6) p < 0.001 0 (0) 1 (0.8) - 
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Table 1. Cont. 
Categorical Variable 
All Controls  
n = 254 
All Cases  
n = 267 
OR (95% CI)  
p Value 
Male Controls 
n = 127 (50.0%) 
Male Cases  
n = 149 (55.8%) 
OR (95% CI)  
p Value 
Female Controls 
n = 127 (50.0%) 
Female Cases  
n = 118 (44.2%) 
OR (95% CI)  
p Value 
Leisure physical activity 
once or more per week 
148 (58.3) 85 (31.8) 0.34 (0.24–0.48) p < 0.001 81 (63.8) 59 (39.9) c 0.38 (0.23–0.61) p < 0.001 67 (52.8) 26 (22.0) 0.25 (0.15–0.44) p < 0.001 
Leisure physical activity 
2-fold or more per week 
104 (40.9) 55 (20.6) 0.38 (0.26–0.55) p < 0.001 60 (47.2) 40 (27.0) c 0.41 (0.25–0.68) p = 0.001 44 (34.6) 15 (12.7) 0.28 (0.14–0.53) p < 0.001 
OR: odds ratio; 95% CI: 95% confidence interval; BMI: body mass index; a 5 patients had missing information about intensity of physical demand at work, thus a total of 
262 patients’ data were available; b 2 male patients had missing information about intensity of physical demand at work, thus a total of 147 data were available; c 1 male 
patient had missing information about leisure physical activity per week, thus a total of 148 data were available; d 3 female patients had missing information about 
intensity of physical demand at work, thus a total of 115 data were available; Only significant p ≤ 0.05 or tendency p ≤ 0.10 were indicated. 
Table 2. Association of VDR-FokI genotypes and alleles in healthy controls and cases, and in males and females. 
Variables 
Controls n = 254 (%) Cases n = 267 (%) Crude OR (95% CI) p Value Adjusted OR 1 (95% CI) p Value 
All 
Subjects 
n = 254 
Males  
n = 127 
(50.0) 
Females  
n = 127 
(50.0) 
All 
Subjects 
n = 267 
Males 
n = 149 
(55.8) 
Females 
n = 118 
(44.2) 
All Subjects  
n = 521 
Males  
n = 276 
Females  
n = 245 
All Subjects Males Females 
VDR-FokI 
genotypes 
FF 101 (39.8) 51 (40.2) 50 (39.4) 117 (43.8) 71 (47.7) 46 (39.0) 1.18 (0.83–1.68) 1.36 (0.84–2.19) 0.98 (0.59–1.64) 1.13 (0.77–1.66) 1.40 (0.79–2.48) 1.08 (0.62–1.88) 
Ff  117 (46.1) 56 (44.1) 61 (48.0) 120 (44.9) 66 (44.3) 54 (45.8) 0.96 (0.68–1.35) 1.01 (0.63–1.62) 0.91 (0.55–1.51) 0.94 (0.64–1.38) 0.97 (0.55–1.72) 0.81 (0.47–1.39) 
ff 36 (14.2) 20 (15.7) 16 (12.6) 30 (11.2) 12 (8.1) 18 (15.3) 0.77 (0.46–1.29) 0.47 (0.22–1.00) p = 0.047 1.25 (0.60–2.58) 0.89 (0.50–1.58) 0.48 (0.19–1.20) 1.34 (0.61–2.92) 
VDR-FokI 
alleles 
F 
319/508 
(62.8) 
158/254 
(62.2) 
161/254 
(63.4) 
354/534 
(66.3) 
208/298 
(69.8) 
146/236 
(61.9) 
1.17 (0.90–1.50) 1.40 (0.99–2.00) p = 0.060 0.94 (0.65–1.35) 1.10 (0.83–1.45) 1.42 (0.93–2.17) 0.97 (0.65–1.43) 
f 
189/508 
(37.2) 
96/254 
(37.8) 
93/254 
(36.6) 
180/534 
(33.7) 
90/298 
(30.2) 
90/236 
(38.1) 
0.86 (0.67–1.11) 0.71 (0.50–1.01) p = 0.060 1.07 (0.74–1.54) 0.91 (0.69–1.21) 0.71 (0.46–1.08) 1.04 (0.70–1.53) 
1 Adjusted OR: multivariate analysis; OR adjusted for age; BMI, family history, smoking, physical job demand and exposure to vibrations; Only significant p ≤ 0.05 or 
tendency p ≤ 0.10 were indicated. 
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Table 3. Association of VDR FokI genotypes with lumbar spine pathologies in males. Total 276 male subjects (127 controls and 149 cases) 
evaluated. Male patients were subdivided in Subgroups 1 to 4 and A to D according to specific pathologic conditions Subgroup 1 = patients with 
disc herniation alone; Subgroup 2 = patients with discopathies and/or osteochondrosis associated with disc herniation; Subgroup 3 = patients with 
discopathies and/or osteochondrosis without herniation; and Subgroup 4 = patients with stenosis and/or spondilolysthesis. Subgroup A, Subgroup 1 
grouped with Subgroup 2 (i.e., all hernia cases with or without concomitant additional conditions); Subgroup B, Subgroup 2 grouped with 
Subgroup 3 (i.e., all discopathies and/or osteochondrosis); Subgroup C, all discopathies cases with or without concomitant disc herniation; 
Subgroup D, all osteochondrosis cases with or without concomitant disc herniation. 
Variables FF n (%) 
Crude OR  
(95% CI) p Value 
Adjusted OR 1 (95% CI) 
p Value 
Ff n (%) 
Crude OR  
(95% CI) p Value 
Adjusted OR 1 
(95% CI) p Value 
ff n (%) 
Crude OR (95% CI)  
p Value 
Adjusted OR 1 (95% CI) 
p Value 
Controls n =127 51 (40.2) - - 56 (44.1) - - 20 (15.7) - - 
Subgroup 1 n = 48 25 (52.1) 1.62 (0.83–3.16) 1.46 (0.65–3.27) 19 (39.6) 0.83 (0.42–1.63) 0.82 (0.37–1.84) 4 (8.3) 0.49 (0.16–1.51) 0.62 (0.18–2.22) 
Subgroup 2 n = 55 29 (52.7) 1.66 (0.88–3.14) 2.32 (1.02–5.30) p = 0.045 23 (41.8) 0.91 (0.48–1.73) 0.72 (0.32–1.62) 3 (5.5) 0.31 (0.09–1.09) p = 0.055 0.24 (0.05–1.14) p = 0.073 
Subgroup 3 n = 21 7 (33.3) 0.75 (0.28–1.97) 0.70 (0.22–2.23) 12 (57.1) 1.69 (0.67–4.30) 2.34 (0.75–7.31) 2 (9.5) 0.56 (0.12–2.61) 0.30 (0.04–2.04) 
Subgroup 4 n = 25 10 (40.0) 0.99 (0.41–2.38) 0.93 (0.33–2.58) 12 (48.0) 1.17 (0.50–2.76) 1.24 (0.47–3.31) 3 (12.0) 0.73 (0.20–2.67) 0.80 (0.19–3.37) 
Subgroup 1 + 2 + 3 
n = 124 
61 (49.2) 1.44 (0.88–2.38) 1.48 (0.81–2.69) 54 (43.5) 0.98 (0.59–1.61) 0.95 (0.52–1.74) 9 (7.3) 0.42 (0.18–0.96) p = 0.035 0.43 (0.16–1.17) p = 0.097 
Subgroup A n = 103 54 (52.4) 1.64 (0.97–2.78) p = 0.063 1.80 (0.94–3.43) p = 0.074 42 (40.8) 0.87 (0.52–1.48) 0.75 (0.39–1.44) 7 (6.8) 0.39 (0.16–0.96) p = 0.036 0.47 (0.16–1.36) 
Subgroup B n = 76 36 (47.4) 1.34 (0.76–2.38) 1.59 (0.78–3.22) 35 (46.1) 1.08 (061–1.92) 1.06 (0.53–2.14) 5 (6.6) 0.38 (0.14–1.05) p = 0.054 0.23 (0.06–0.88) p = 0.032 
Subgroup C n = 27 16 (59.3) 2.17 (0.93–5.05) p = 0.069 2.59 (0.89–7.50) p = 0.079 10 (37.0) 0.75 (0.32–1.76) 0.67 (0.23–1.90) 1 (3.7) 0.21 (0.03–1.60) p = 0.098 0.18 (0.02–1.84) 
Subgroup D n = 40 19 (47.5) 1.35 (0.66–2.76) 1.94 (0.79–4.79) 19 (47.5) 1.15 (0.56–2.34) 0.90 (0.37–2.16) 2 (5.0) 0.28 (0.06–1.26) p = 0.080 0.22 (0.04–1.31) p = 0.096 
1 Adjusted OR: multivariate analysis; OR adjusted for age; BMI, family history, smoking, physical job demand and exposure to vibrations; Only significant p ≤ 0.05 or 
tendency p ≤ 0.10 were indicated. 
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Table 4. Association of VDR FokI genotypes and lumbar spine pathologies in females. Total 245 female subjects (127 controls and 118 cases) 
evaluated. Female patients were subdivided in Subgroups 1 to 4 and A to D according to specific pathologic conditions. Subgroup 1 = patients 
with disc herniation alone; Subgroup 2 = patients with discopathies and/or osteochondrosis associated with disc herniation; Subgroup 3 = patients 
with discopathies and/or osteochondrosis without herniation; and Subgroup 4 = patients with stenosis and/or spondilolysthesis. Subgroup A, 
Subgroup 1 grouped with Subgroup 2 (i.e., all hernia cases with or without concomitant additional conditions); Subgroup B, Subgroup 2 
grouped with Subgroup 3; Subgroup C, all discopathies cases with or without concomitant disc herniation; Subgroup D, all osteochondrosis 
cases with or without concomitant disc herniation. 
Variables FF n (%) 
Crude OR  
(95% CI)  
p Value 
Adjusted OR 1 
(95% CI)  
p Value 
Ff n (%) 
Crude OR 
(95% CI)  
p Value 
Adjusted OR 1 
(95% CI)  
p Value 
ff n (%) 
Crude OR  
(95% CI)  
p Value 
Adjusted OR 1  
(95% CI)  
p Value 
Controls n = 127 50 (39.4) - - 61 (48.0) - - 16 (12.6) - - 
Subgroup 1 n = 41 12 (29.3) 0.64 (0.30–1.36) 0.75 (0.34–1.66) 21 (51.2) 1.14 (0.56–2.30) 0.96 (0.45–2.04) 8 (19.5) 1.68 (0.66–4.28) 1.81 (0.65–4.99) 
Subgroup 2 n = 32 20 (62.5) 
2.57 (1.15–5.71) 
p = 0.018 
2.48 (1.07–5.74) 
p = 0.034 
9 (28.1) 
0.42 (0.18–0.99) 
p = 0.043 
0.38 (0.16–0.93) 
p = 0.033 
3 (9.4) 0.72 (0.20–2.63) 1.02 (0.25–4.06) 
Subgroup 3 n = 19 7 (36.8) 0.90 (0.33–2.44) 0.90 (0.32–2.54) 11 (57.9) 1.49 (0.56–3.94) 1.41 (0.50–3.96) 1 (5.3) 0.39 (0.05–3.09) 0.43 (0.05–3.72) 
Subgroup 4 n = 26 7 (26.9) 0.57 (0.22–1.45) 0.55 (0.19–1.57) 13 (50.0) 1.08 (0.47–2.52) 0.89 (0.34–2.30) 6 (23.1) 2.08 (0.73–5.96) 
3.20 (0.94–11.0)  
p = 0.064 
Subgroup 1 + 2 + 3 n = 92 39 (42.4) 1.13 (0.66–1.96) 1.25 (0.70–2.24) 41 (44.6) 0.87 (0.51–1.49) 0.77 (0.43–1.37) 12 (13.0) 1.04 (0.47–2.32) 1.10 (0.46–2.59) 
Subgroup A n = 73 32 (43.8) 1.20 (0.67–2.15) 1.30 (0.69–2.42) 30 (41.1) 0.76 (0.42–1.35) 0.67 (0.36–1.25) 11 (15.1) 1.23 (0.54–2.82) 1.39 (0.56–3.44) 
Subgroup B n = 51 27 (52.9) 
1.73 (0.90–3.34) 
p = 0.098 
1.74 (0.88–3.46) 20 (39.2) 0.70 (0.36–1.35) 0.64 (0.32–1.28) 4 (7.8) 0.59 (0.19–1.86) 0.71 (0.21–2.36) 
Subgroup C n = 37 21 (56.8) 
2.02 (0.96–4.24) 
p = 0.060 
1.88 (0.87–4.08) 12 (32.4) 
0.52 (0.24–1.12) 
p = 0.093 
0.49 (0.22–1.10) 
p = 0.083 
4 (10.8) 0.84 (0.26–2.69) 1.07 (0.31–3.65) 
Subgroup D n = 10 5 (50.0) 1.54 (0.42–5.59) 1.62 (0.43–6.06) 5 (50.0) 1.08 (0.30–3.92) 1.01 (0.26–3.85) 0 (-) - - 
1 Adjusted OR: multivariate analysis; OR adjusted for age; BMI, family history, smoking, physical job demand and exposure to vibrations; Only significant p ≤ 0.05 or 
tendency p ≤ 0.10 were indicated. 
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Regarding the female population (Table 4) in Subgroup 2 the FF genotype had a frequency of 
62.5% vs. 39.4% of female controls (crude OR = 2.57; 95% CI = 1.15–5.71, p = 0.018; adjusted  
OR = 2.48, 95% CI = 1.07–5.74, p = 0.034), while the heterozygous Ff genotype was protective (crude 
OR = 0.42; 95% CI = 0.18–0.99, p = 0.043; adjusted OR = 0.38, 95% CI = 0.16–0.93, p = 0.033).  
No other significant finding was observed for FokI genotypes in female Subgroups. An intriguing 
observation was that the ff genotype showed a tendency for risk in the female Subgroup 4 (adjusted  
OR = 3.20, 95% CI = 0.94–11.0, p = 0.064). 
FokI alleles associations with detailed lumbar pathologic conditions in the entire sample including 
both sexes are reported in the Supplementary file (Supplementary Table S2). The F allele was a risk 
factor for several Subgroups of patients (and consequently the f allele was protective) as follow: 
Subgroup 2 (crude OR = 1.75; 95% CI = 1.19–2.58, p = 0.004; adjusted OR = 1.76; 95% CI = 1.14–2.73,  
p = 0.011); Subgroup A (crude OR = 1.34; 95% CI = 1.00–1.79, p = 0.048; adjusted OR not 
significant); Subgroup B (crude OR = 1.47; 95% CI = 1.06–2.04, p = 0.020; adjusted OR = 1.49;  
95% CI = 1.04–2.13, p = 0.032), and Subgroup C (crude OR = 1.78; 95% CI = 1.15–2.76, p = 0.010; 
adjusted OR = 1.64; 95% CI = 1.02–2.62, p = 0.040). 
Gender related FokI alleles associations with detailed lumbar pathologic conditions were reported in 
Tables 5 (males) and 6 (females). 
In males (Table 5) frequency of the F allele was almost 2-fold higher in several Subgroups of 
patients. Specifically, Subgroup 2 (crude OR = 1.70; 95% CI = 1.04–2.78, p = 0.035; adjusted  
OR = 2.16; 95% CI = 1.15–4.05, p = 0.017), Subgroup 1 + 2 + 3 (crude OR = 1.49; 95% CI = 1.02–2.16,  
p = 0.038; adjusted OR = 1.50; 95% CI = 0.95–2.35, p = 0.080), Subgroup A (crude OR = 1.63;  
95% CI = 1.09–2.42, p = 0.016; adjusted OR = 1.66; 95% CI = 1.02–2.70, p = 0.042), Subgroup B 
(crude OR = 1.45; 95% CI = 0.94–2.22, p = 0.093; adjusted OR = 1.72; 95% CI = 1.01–2.95,  
p = 0.048), and Subgroup C (crude OR = 2.13; 95% CI = 1.07–4.24, p = 0.029; adjusted OR = 2.36; 
95% CI = 1.02–5.44, p = 0.044) in respect to male controls. Consequently the f allele was protective 
for male patients of Subgroups 2, 1 + 2 + 3, A, B, and C. 
As shown in Table 6, no significant finding was observed for FokI alleles in specific subgroups of 
female patients, with the exception of Subgroup 2 for which the F allele (frequency 76.6% in female 
cases vs. 63.4% in female controls) in a crude analysis had almost 2-fold increased risk (crude OR = 1.89; 
95% CI = 1.00–3.55, p = 0.047; adjusted OR not significant). Consequently the f allele in females was 
protective for Subgroup 2, although significance was lost in adjusted analysis. Of note, an inverse trend 
was observed for the f allele in female Subgroup 4 (f frequency 48.1% vs. 36.6% of female controls), 
crude OR not significant; adjusted OR = 1.82; 95% CI = 0.92–3.59; p = 0.085. Overall in our study,  
the Subgroup 4 (i.e., stenosis and/or spondilolysthesis) seems to differ in respect to all other Subgroups. 
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Table 5. Association of VDR FokI alleles with lumbar spine pathologies in males. Total 276 male subjects (127 controls and 149 cases) 
evaluated. Male patients were subdivided in Subgroups 1 to 4 and A to D according to specific pathologic conditions. Subgroup 1 = patients with 
disc herniation alone; Subgroup 2 = patients with discopathies and/or osteochondrosis associated with disc herniation; Subgroup 3 = patients 
with discopathies and/or osteochondrosis without herniation; and Subgroup 4 = patients with stenosis and/or spondilolysthesis. Subgroup A, 
Subgroup 1 grouped with Subgroup 2 (i.e., all hernia cases with or without concomitant additional conditions); Subgroup B, Subgroup 2 
grouped with Subgroup 3; Subgroup C, all discopathies cases with or without concomitant disc herniation; Subgroup D, all osteochondrosis 
cases with or without concomitant disc herniation. 
Male Subjects 
Variables F n (%) Crude OR (95% CI) p Value 
Adjusted OR 1 (95% CI)  
p Value 
f n (%) 
Crude OR (95% CI)  
p Value 
Adjusted OR 1 (95% CI) 
p Value 
Controls n = 254 158 (62.2) - - 96 (37.8) - - 
Subgroup 1 n = 96 69 (71.9) 1.55 (0.93–2.59) p = 0.091 1.37 (0.75–2.50) 27 (28.1) 0.64 (0.39–1.08) p = 0.091 0.73 (0.40–1.34) 
Subgroup 2 n = 110 81 (73.6) 1.70 (1.04–2.78) p = 0.035 2.16 (1.15–4.05) p = 0.017 29 (26.4) 0.59 (0.36–0.97) p = 0.035 
0.46 (0.25–0.87)  
p = 0.017 
Subgroup 3 n = 42 26 (61.9) 0.99 (0.50–1.93) 1.09 (0.50–2.37) 16 (38.1) 1.01 (0.52–1.98) 0.92 (0.42–2.01) 
Subgroup 4 n = 50 32 (64.0) 1.08 (0.58–2.03) 1.01 (0.49–2.09) 18 (36.0) 0.93 (0.49–1.74) 0.99 (0.48–2.03) 
Subgroup 1 + 2 + 3 n = 248 176 (71.0) 1.49 (1.02–2.16) p = 0.038 1.50 (0.95–2.35) p = 0.080 72 (29.0) 0.67 (0.46–0.98) p = 0.038 
0.67 (0.43–1.05)  
p = 0.080 
Subgroup A n = 206 150 (72.8) 1.63 (1.09–2.42) p = 0.016 1.66 (1.02–2.70) p = 0.042 56 (27.2) 0.61 (0.41–0.92) p = 0.016 
0.60 (0.37–0.98)  
p = 0.042 
Subgroup B n = 152 107 (70.4) 1.45 (0.94–2.22) p = 0.093 1.72 (1.01–2.95) p = 0.048 45 (29.6) 0.69 (0.45–1.07) p = 0.093 
0.58 (0.34–0.99)  
p = 0.048 
Subgroup C n = 54 42 (77.8) 2.13 (1.07–4.24) p = 0.029 2.36 (1.02–5.44) p = 0.044 12 (22.2) 0.47 (0.24–0.94) p = 0.029 
0.42 (0.18–0.98)  
p = 0.044 
Subgroup D n = 80 57 (71.3) 1.51 (0.87–2.60) 1.92 (0.97–3.80) p = 0.060 23 (28.8) 0.66 (0.38–1.15) 
0.52 (0.26–1.03)  
p = 0.060 
1 Adjusted OR: multivariate analysis; OR adjusted for age; BMI, family history, smoking, physical job demand and exposure to vibrations; Only significant p ≤ 0.05 or 
tendency p ≤ 0.10 were indicated. 
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Table 6. Association of VDR FokI alleles with lumbar spine pathologies in females. Total 245 female subjects (127 controls and 118 cases) 
evaluated. Female patients were subdivided in Subgroups 1 to 4 and A to D according to specific pathologic conditions. Subgroup 1 = patients 
with disc herniation alone; Subgroup 2 = patients with discopathies and/or osteochondrosis associated with disc herniation; Subgroup 3 = patients 
with discopathies and/or osteochondrosis without herniation; and Subgroup 4 = patients with stenosis and/or spondilolysthesis. Subgroup A, 
Subgroup 1 grouped with Subgroup 2 (i.e., all hernia cases with or without concomitant additional conditions); Subgroup B, Subgroup 2 
grouped with Subgroup 3; Subgroup C, all discopathies cases with or without concomitant disc herniation; Subgroup D, all osteochondrosis 
cases with or without concomitant disc herniation. 
Female Subjects 
Variables F n (%) 
Crude OR (95% CI)  
p Value 
Adjusted OR 1 (95% CI)  
p Value 
f n (%) 
Crude OR (95% CI)  
p Value 
Adjusted OR 1 (95% CI)  
p Value 
Controls n = 254 161 (63.4) - - 93 (36.6) - - 
Subgroup 1 n = 82 45 (54.9) 0.70 (0.42–1.16) 0.75 (0.44–1.28) 37 (45.1) 1.42 (0.86–2.36) 1.33 (0.78–2.27) 
Subgroup 2 n = 64 49 (76.6) 1.89 (1.00–3.55) p = 0.047 1.71 (0.89–3.28) 15 (23.4) 0.53 (0.28–1.00) p = 0.047 0.59 (0.31–1.13) 
Subgroup 3 n = 38 25 (65.8) 1.11 (0.54–2.28) 1.08 (0.52–2.26) 13 (34.2) 0.90 (0.44–1.84) 0.93 (0.44–1.94) 
Subgroup 4 n = 52 27 (51.9) 0.62 (0.34–1.14) 0.55 (0.28–1.09) p = 0.085 25 (48.1) 1.60 (0.88–2.92) 1.82 (0.92–3.59) p = 0.085 
Subgroup 1 + 2+ 3 n = 184 119 (64.7) 1.06 (0.71–1.57) 1.10 (0.73–1.67) 65 (35.3) 0.95 (0.64–1.41) 0.91 (0.60–1.38) 
Subgroup A n = 146 94 (64.4) 1.04 (0.68–1.60) 1.06 (0.68–1.67) 52 (35.6) 0.96 (0.63–1.46) 0.94 (0.60–1.48) 
Subgroup B n = 102 74 (72.5) 1.53 (0.92–2.53) p = 0.099 1.45 (0.86–2.44) 28 (27.5) 0.66 (0.40–1.09) p = 0.099 0.69 (0.41–1.16) 
Subgroup C n = 74 54 (73.0) 1.56 (0.88–2.77) 1.40 (0.77–2.53) 20 (27.0) 0.64 (0.36–1.14) 0.72 (0.40–1.29) 
Subgroup D n = 20 15 (75.0) 1.73 (0.61–4.92) 1.74 (0.60–5.00) 5 (25.0) 0.58 (0.20–1.64) 0.58 (0.20–1.66) 
1 Adjusted OR: multivariate analysis; OR adjusted for age; BMI, family history, smoking, physical job demand and exposure to vibrations; Only significant p ≤ 0.05 or 
tendency p ≤ 0.10 were indicated. 
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3. Discussion 
Accumulating evidence highlights that gender-related medicine may have a major impact in 
evaluation of incidence, prognosis and optimal treatment of several diseases. Notably, gender 
disparities were evident in risk factors for several pathologic conditions including osteoporosis, cancer 
and cardiovascular diseases [22]. However, gender differences in lumbar spine pathologies were 
minimally explored [23]; no study, to our knowledge, investigated this issue in the Italian population. 
In our present study, interesting results emerged from the analysis of the association of non-genetic 
conventional, behavioral and environmental categorical variables with development of lumbar spine 
pathologies in the overall cohort of cases and in both sexes compared to appropriate controls. In the 
entire sample, we observed an association between lumbar spine pathologies and higher number of 
hours/day exposure to vibration with a strong dose-response effect, a more physically demanding 
rather than sedentary job, and the physical intensity of a job. Notably, this risk profile was confirmed only 
in males. Among the other putative conventional risk factors analyzed, we observed that, in our entire 
sex-unstratified pathological sample, family history, higher age (≥45 years), overweight (≥25.0 kg/m2) and 
smoking habits were associated with an approximately 2-fold risk for lumbar spine pathologies. Of note, 
heavy smoking (≥20 cigarettes/day) was associated with a six-fold increased risk. These findings 
concerning smoking habits are in accordance with previous investigations showing that smoking can 
accelerate disc degeneration and induce back pain [25,26], and is also an important risk factor for 
recurrent disc herniation [27]. 
Overall, our findings highlighted that voluntary behaviors, in addition to environmental factors, are 
major determinants in lumbar spine pathologies. Notably, we found that women appeared to have less of 
the noted risky behaviors. 
Interestingly, all the conventional risk factors observed in the sex-unstratified cohort were 
associated with a pathological phenotype in male patients, while in females patients only family 
history, higher age, overweight and lower voluntary practice of leisure physical activity were 
determinant of risk. In general, the female population was less exposed to environmental and 
occupational risk factors, which could account for a gender-specific influence regarding the pathological 
phenotype. In line with our findings, a different prevalence for risk factors associated to back pain 
according to gender was observed by other authors in the Canadian (Quebec) population [23]. 
In a recently published paper we determined FokI genotypes and alleles in this sample of lumbar 
spine pathologic Italian white subjects enrolled in Milan (Northern Italy) [21]. We now compared them 
with 254 healthy controls including equal number of males and females. 
Analysis of FokI polymorphism considering the heterogeneous group comprising all patients having 
lumbar pathologies according to gender did not reveal significant findings with the exception of a just 
significant protective effect of ff genotype and a tendency for protection of the f allele in males. 
Increasing evidence suggests that specific subgroups of patients with specific pathological features 
should be investigated separately, thus, we adopted the same approach used in our previous paper [21].  
Confirmatory with previous findings, FF genotype was associated with roughly a two-fold 
increased risk for discopathies and/or osteochondrosis concomitant with herniation after adjusting for 
risk factors in the entire population, and also in separately analyzed males and females. By adjusted 
analysis, the FF genotype was associated with roughly a two-fold increased risk for discopathies in 
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general in the entire population, but considering the male and female populations separately significance 
was lost and only a tendency was observed. According to sex-unstratified adjusted analysis, the  
F allele was associated with increased risk in patients having discopathies and/or osteochondrosis 
concomitant with herniation (Subgroup 2), all patients having discopathies and also in all patients 
having discopathies and/or osteochondrosis. All the associations were confirmed in males, while in 
females the F allele was a risk factor in crude analysis only for Subgroup 2. 
Regarding patients with stenosis and/or spondylolisthesis, sex-unstratified analysis found no significant 
associations or tendencies. It is interesting to note, however, that in the gender analysis, in females FokI 
polymorphism showed an opposite tendency; the F allele seemed to be protective, while the f allele 
seemed to be associated and the ff genotype showed a risky tendency (p = 0.064). 
The wild-type VDR F allele is considered to produce a more transcriptionally active receptor protein 
than the f allele [4–6]. Consequently, FF homozigosity should enhance vitamin D final effects and, 
thus, favor discopathies and the severe progression of discopathy and/or osteochondrosis to herniation. 
On the contrary, a reduced transcriptional activity of VDR, which is likely to occur in ff homozygous 
subjects, seems to favor stenosis and/or spondylolisthesis, especially in women. 
Of note, a study performed in a geographically isolated population of both pre- and postmenopausal 
Italian women of the island of Lampedusa (located between the African coast and Sicily), showed that 
the ff genotype was associated with lower lumbar spine bone mass in comparison with Ff and  
FF genotypes [28]. 
Interestingly, a very recent study performed in 140 Iranian subject with diabetes evidenced that the 
VDR ff genotype was associated to lower vitamin D levels and this homozigosity may be regarded as 
“low responders” to vitamin D intake [29]. 
Several lines of evidence indicate that vitamin D homeostasis differs between men and women. 
Interestingly, it was found that women have lower levels of circulating vitamin D than men [30], and this 
effect was also observed in the Italian population [31]. However, it is not clear if this depends mainly on 
external factors or if the gender difference could be related to a differential vitamin D homeostasis in the 
two sexes [29,32]. It is tempting to speculate that a nutrigenic approach based on specific genotypes may 
be needed to protect patients with specific lumbar spine disorders, with particular attention to the 
gender-related differences. 
A limitation of our study is the sample size. Stratification by gender and by pathological Subgroups 
reduced the number of subjects compared. An increase in the number of male and female cases  
and gender-matched controls will be necessary to strengthen statistical power and substantiate  
gender-related differences. Particularly, an increase in the number of subjects with stenosis and/or 
spondylolisthesis appears important to confirm if the observed opposite trend in term of the type  
of FokI allele associated to risk in these diseases is due to specific pathological features and/or is 
strictly gender-related. 
In the future, it could be interesting to perform tissue specific studies analyzing the interplay between 
the different VDR variants and its ligand to give a biological explanation of the associations observed in 
patients. Moreover the authors should evaluate whether a particular vitamin D status, circulating levels 
and/or polymorphisms of vitamin D binding protein (DBP), diet or medications for treatment of 
neuropathic pain could affect vitamin D metabolism, thus predisposing to the development or 
progression of spine pathologies. 
Int. J. Mol. Sci. 2015, 16 3735 
 
 
In conclusion, we here report the novel gender-related association of the functional VDR-FokI 
polymorphism and of the concomitant conventional risk factors with specific spine pathologies in the 
Italian white population. 
In our opinion, the observation of pronounced gender differences could be crucial for the prospect of a 
personalized medicine approach and seems to strongly indicate the necessity of a gender-differentiated 
management of patients with lumbar spine disorders. 
4. Experimental Section 
4.1. Subjects and Clinical Assessment 
Using a case-control design, 267 (149 males, 118 females) consecutive patients (hospitalized or 
outpatients) with lumbar spine disorders recruited for the European Genodisc Project and 254  
(127 males, 127 females) asymptomatic controls (most were healthy volunteers, some were blood 
donors, few were subjects hospitalized for anterior cruciate ligament injuries or hallux valgus surgery) 
were enrolled at the I.R.C.C.S. Istituto Ortopedico Galeazzi (Milan, Italy). All subjects signed a written 
informed consent. Cases and controls were enrolled from May 2009 to December 2013. The study was 
approved by the Institutional Review Board ASL Città di Milano (Milano, Italy). The methods used in 
this study were in accordance with the Helsinki Declaration of 1975 as revised in 1996. The cohort of 
cases was the same of our previous published paper and inclusion/exclusion criteria for both cases and 
controls were previously reported [21]. However, in respect to our previous investigation the number 
of controls was increased including 21 more males and 13 more females, thus final number of controls 
(n = 254) comprised an equal number of males (n = 127) and females (n = 127). 
Assessment of lumbar spine disorders and patient classification into subgroups based on detailed 
diagnosis were performed by an expert clinician in spine diseases by contrast-enhanced MRI 12 scans of 
the lumbar spine with a 1.5 T scanner (Avanto, Siemens, Erlangen, Germany) as described in our 
previous paper [21]. 
4.2. Conventional, Behavioral and Environmental Factors Evaluation 
A questionnaire reporting the exposure to putative risk factors known from various studies as 
affecting the susceptibility to spine disorders [24] was obtained from each subject. The collected 
information included: family history (parents, brothers or sisters) of spine disorders, smoking habit,  
job physical demand for the majority of the working years (evaluated by the following score:  
0 = sedentary; 1 = light; 2 = medium; 3 = heavy), hours/day spent driving or as a passenger in 
motorized vehicles (exposure to vibrations) and, finally, over the past year, the times a week spent in 
vigorous physical activity outside work involving twisting, bending or lifting, collectively indicated 
hereafter as leisure physical activity. 
4.3. Determination of VDR-FokI Polymorphism 
Blood samples were collected from the antecubital vein with evacuated ethylenediamine tetra acetic 
acid (EDTA) tubes (Vacutainer Tubes, Becton-Dickinson, Franklin Lakes, NJ, USA) from all the 
enrolled subjects. Genomic DNA was extracted according to the procedure of the DNeasy Midi kit 
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(Qiagen, Duesseldorf, Germany). Polymerase chain reaction and restriction fragment length 
polymorphism (PCR-RFLP) methods were applied to detect the VDR-FokI polymorphism as 
previously reported [21]. 
Genotypes were designated by a lowercase letter (f allele, T nucleotide, mutated) for the presence of 
the restriction site and by a capital letter (F allele, C nucleotide, wild-type) for its absence. 
4.4. Statistical Analysis 
Kolmogorov-Smirnov test was used to assess the normal data distribution. Student’s t-test or  
Mann Whitney test were used to assess the differences between the frequency distributions of variables 
in cases and controls. ORs were calculated to set the association between specific categorical variables, 
alleles or genotypes and risk of spine pathologies in cases, controls, and subgroups of patients 
including males and females. Chi squared or Fisher’s exact test p values were reported as appropriate. 
Logistic regression was used to evaluate effects of confounders by obtaining adjusted ORs and  
95% CIs for genotypes and alleles. Adjusted analysis included conventional risk factors: age, BMI, 
family history, smoke, physical job demand and exposure to vibrations. Leisure physical activity was 
not included as confounding because this kind of activity may derive both by personal sedentary habits 
and by absence of spine pain. 
Significance level was held at 0.05. At variance, p values ≤0.10 were considered as a tendency.  
Statistical softwares used were GraphPad Prism version 5.00 (GraphPad software, La Jolla, CA, USA) 
and SPSS version 14.0 (SPSS Inc., Chicago, IL, USA). 
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Supplementary materials can be found at http://www.mdpi.com/1422-0067/16/02/3722/s1. 
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